KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $81.0 million.

  • Johnson & Johnson's Asset Writedowns and Impairment rose 21153.85% to $81.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $204.0 million, marking a year-over-year decrease of 4962.96%. This contributed to the annual value of $204.0 million for FY2025, which is 4962.96% down from last year.
  • Latest data reveals that Johnson & Johnson reported Asset Writedowns and Impairment of $81.0 million as of Q4 2025, which was up 21153.85% from $93.0 million recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's Asset Writedowns and Impairment ranged from a high of $1.0 billion in Q4 2021 and a low of -$66.0 million during Q3 2021
  • Over the past 5 years, Johnson & Johnson's median Asset Writedowns and Impairment value was $139.0 million (recorded in 2024), while the average stood at $235.3 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first crashed by 16947.37% in 2021, then surged by 425714.29% in 2022.
  • Over the past 5 years, Johnson & Johnson's Asset Writedowns and Impairment (Quarter) stood at $1.0 billion in 2021, then crashed by 39.96% to $610.0 million in 2022, then fell by 22.13% to $475.0 million in 2023, then tumbled by 94.53% to $26.0 million in 2024, then surged by 211.54% to $81.0 million in 2025.
  • Its Asset Writedowns and Impairment was $81.0 million in Q4 2025, compared to $93.0 million in Q3 2025 and $30.0 million in Q1 2025.